Patent · US Active

Treprostinil derivatives and compositions and uses thereof

US9643911B2 · kind B2 · utility

22Cited by

48References

11Claims

0Family size

Assignee

Corsair Pharma, Inc. · US

Inventors

Xiaoming Zhang · Beijing, CN
Meenakshi S. Venkatraman · Fremont, US
Cyrus K. BECKER · Fremont, US

Key dates

Filing date	Aug 18, 2015
Grant date	May 9, 2017
Priority date	—
Expiry date	Aug 18, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.